Loading the section
Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 16, 2026 | 121.48 | 124.96 | 121.48 | 124.75 | 1m |
| September 15, 2026 | 121.58 | 122.19 | 119.97 | 121.74 | 2m |
| September 14, 2026 | 122.48 | 123.35 | 121.28 | 122.19 | 1m |
| September 11, 2026 | 124.35 | 124.35 |
Based on reports through December 31, 2025
Incyte was built around a single drug for a bone marrow disease and is looking for what will replace it.
The main drug suppresses the signalling pathway that makes bone marrow produce cells incorrectly. It remains the standard of care and supplies the overwhelming share of revenue. That dependence is both a strength and a vulnerability: patent protection has an end date, and the cliff is visible in the calendar well in advance.
A replacement is sought in two directions: a cream for vitiligo and eczema working through the same mechanism, and drugs against particular tumour types. The company is profitable, which is rare for a biotech, and reinvests that profit into development. Risks: the patent term, trial outcomes and insurers' decisions on covering an expensive cream. The company pays no dividend.
Address:1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803, US
| 112m |
| BIAFbioAffinity Technologies, Inc. | 8.36 | +5,590.70 % | 52m |
| ABSIAbsci Corporation | 9.42 | +1,715.40 % | 24m |
| OABIOmniAb, Inc. | 4.41 | +137.90 % | 9m |
| NRCNRC Health | 20.89 | −528.30 % | 3m |
| 121.42 |
| 121.47 |
| 1m |
| September 10, 2026 | 125.09 | 126.31 | 122.58 | 123.28 | 1m |
| September 09, 2026 | 125.66 | 127.72 | 123.57 | 126.01 | 1m |
| September 08, 2026 | 124.11 | 126.40 | 122.22 | 124.40 | 1m |
| September 04, 2026 | 126.46 | 128.08 | 126.04 | 126.75 | 1m |
| September 03, 2026 | 129.67 | 130.00 | 126.20 | 128.00 | 909,800 |
| September 02, 2026 | 126.43 | 129.56 | 125.89 | 128.83 | 2m |
| September 01, 2026 | 124.61 | 125.14 | 122.50 | 125.01 | 1m |
| August 31, 2026 | 122.66 | 124.00 | 121.61 | 123.22 | 1m |
| August 28, 2026 | 127.74 | 127.74 | 123.08 | 124.37 | 1m |
| August 27, 2026 | 128.13 | 128.20 | 126.06 | 127.74 | 700,400 |
| August 26, 2026 | 129.18 | 129.54 | 127.77 | 128.12 | 800,100 |
| August 25, 2026 | 128.98 | 130.80 | 127.50 | 129.72 | 1m |
| August 24, 2026 | 127.47 | 128.36 | 126.31 | 127.98 | 799,500 |
| August 21, 2026 | 126.45 | 129.92 | 125.60 | 127.81 | 1m |
| August 20, 2026 | 127.10 | 129.80 | 126.71 | 127.22 | 1m |
| August 19, 2026 | 125.00 | 129.56 | 124.60 | 128.47 | 2m |